Follow
Ken Miles
Ken Miles
Verified email at ucl.ac.uk
Title
Cited by
Cited by
Year
Imaging biomarker roadmap for cancer studies
JPB O'connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ...
Nature reviews Clinical oncology 14 (3), 169-186, 2017
10142017
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?
F Davnall, CSP Yip, G Ljungqvist, M Selmi, F Ng, B Sanghera, ...
Insights into imaging 3, 573-589, 2012
9072012
Measurement of tissue perfusion by dynamic computed tomography
KA Miles
The British journal of radiology 64 (761), 409-412, 1991
7581991
Perfusion CT: a worthwhile enhancement?
KA Miles, MR Griffiths
The British journal of radiology 76 (904), 220-231, 2003
7502003
Functional images of hepatic perfusion obtained with dynamic CT.
KA Miles, MP Hayball, AK Dixon
Radiology 188 (2), 405-411, 1993
6651993
Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival
B Ganeshan, E Panayiotou, K Burnand, S Dizdarevic, K Miles
European radiology 22, 796-802, 2012
5442012
Perfusion CT for the assessment of tumour vascularity: which protocol?
KA Miles
The British journal of radiology 76 (suppl_1), S36-S42, 2003
5262003
Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review
KA Miles
European journal of radiology 30 (3), 198-205, 1999
5161999
Colour perfusion imaging: a new application of computed tomography
KA Miles, M Hayball, AK Dixon
The Lancet 337 (8742), 643-645, 1991
4881991
Non–small cell lung cancer: histopathologic correlates for texture parameters at CT
B Ganeshan, V Goh, HC Mandeville, QS Ng, PJ Hoskin, KA Miles
Radiology 266 (1), 326-336, 2013
4772013
Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival
F Ng, B Ganeshan, R Kozarski, KA Miles, V Goh
Radiology 266 (1), 177-184, 2013
4632013
Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection
A Bolia, KA Miles, J Brennan, PRF Bell
Cardiovascular and interventional radiology 13, 357-363, 1990
4481990
Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker
V Goh, B Ganeshan, P Nathan, JK Juttla, A Vinayan, KA Miles
Radiology 261 (1), 165-171, 2011
3882011
Application of CT in the investigation of angiogenesis in oncology
KA Miles, C Charnsangavej, FT Lee, EK Fishman, K Horton, TY Lee
Academic radiology 7 (10), 840-850, 2000
3792000
Quantifying tumour heterogeneity with CT
B Ganeshan, KA Miles
Cancer imaging 13 (1), 140, 2013
3732013
Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage
B Ganeshan, S Abaleke, RCD Young, CR Chatwin, KA Miles
Cancer imaging 10 (1), 137, 2010
3622010
Functional computed tomography in oncology
KA Miles
European Journal of Cancer 38 (16), 2079-2084, 2002
343*2002
Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival
B Ganeshan, K Skogen, I Pressney, D Coutroubis, K Miles
Clinical radiology 67 (2), 157-164, 2012
3402012
CT texture analysis using the filtration-histogram method: what do the measurements mean?
KA Miles, B Ganeshan, MP Hayball
Cancer Imaging 13 (3), 400, 2013
3042013
Colorectal Cancer: Texture Analysis of Portal Phase Hepatic CT Images as a Potential Marker of Survival1
KA Miles, B Ganeshan, MR Griffiths, RCD Young, CR Chatwin
Radiology 250 (2), 444-452, 2009
2792009
The system can't perform the operation now. Try again later.
Articles 1–20